Medtronic Appoints Dr. James Porter as Chief Medical Officer for Robotic and Digital Technologies

Sep 13, 2024 11:50 CST Updated 11:50

Medtronic

Chronic Disease Medical Device and Therapy Developer

Source: MedRobot; Editor: Sophia

Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.

Endoscopic Surgical Robot Products Course

MedRobot

On September 12, 2024, Medtronic announced that Dr. James Porter has joined the company asChief Medical Officer (CMO) of Robotic Surgery and Digital Technology。

# Personal Resume

Dr. Porter is a practicing urological surgeon with experience in more than 5,000 robot-assisted surgeries, recognized as one of the global leaders in the surgical community and one of the top robotic surgery doctors in the United States.

He specializes in prostate cancer, kidney cancer, and urological surgeries, making significant contributions to the field of urology, including advancements in several pioneering surgical techniques for treating renal tumors and testicular cancer in young men.

Dr. Porter said that surgery is rapidly evolving due to the development of robotics and digital technology.Medtronic's Hugo™ and Touch Surgery™ technologies are at the forefront in this area.

Before joining Medtronic, Dr. Porter was in Seattle, Washington.Providence Swedish Serving as the Medical Director of Robotic Surgery, he helped establish one of the largest multi-specialty robotic surgery programs in the United States. He will continue to perform surgeries part-time at Providence Swedish.

As the CMO of robotics and digital technology in Medtronic's surgical business, Dr. Porter will drive the strategic direction focused on patients, robotic and digital innovations, clinical evidence programs, as well as physician and community engagement.

He will also attend the European Robotic Urology Symposium (ERUS) in Bordeaux, France, where he will use the Hugo™ system to demonstrate a partial nephrectomy during the live surgery session of the conference.

# Conference Information

European Robotic Urology Society(ERUS) 24th Meeting was held in Bordeaux, France, from September 11 to 13, 2024.

The conference will focus on practical guidance for robotic surgery through live surgeries, case discussions, and state-of-the-art lectures. In addition, the conference will also offer opportunities for industry meetings, European School of Urology (ESU) courses, and technical forums.

Medtronic, as the Platinum Sponsor of the ERUS conference,The Hugo™ Surgical Robot and Touch Surgery™ Ecosystem, including the recently added Live Stream technology, will be demonstrated at the booth.

▲

Hugo™ Surgical Robot

▲ Touch Surgery™ Ecosystem

# Hugo Expanded Indications

On May 24, 2024, Medtronic announced the launch of additional clinical studies for its Hugo robotic-assisted surgery system to expand its indications.Hernia Repair SurgeryAndGynecological Field。

Two Clinical Studies

The clinical trial in the United States began at Duke University Hospital in Durham.Robot-Assisted Bilateral Inguinal Hernia Repair Surgery, conducted by the national principal investigator of the trial, Dr. Jacob Greenberg.

This clinical trial is a prospective, multicenter study evaluating the safety and performance of Hugo RAS to support FDA submission.

In addition, Medtronic has also launched aFor Gynecological SurgeryProspective clinical study.

Previously, Medtronic launched the Hugo surgical robotThe First IDE Study: Expand URO Clinical Trial.

The research focuses on urological surgeries, such as prostatectomy, radical cystectomy, and nephrectomy (partial or radical). Urological surgeries are currently the most common type of soft tissue procedures performed by surgical robots.

In October 2021, Medtronic's Hugo RAS system received EU CE certification,Approved for sale in Europe, used in urology and gynecology surgeries. This is an important milestone in the commercialization of the Hugo RAS system.

# AI Empowerment

In July 2024, Medtronic announced itsTouch Surgery Digital Surgical SystemUpdatedLive streaming feature, including 14 new AI algorithms, can enhance postoperative analysis functions.Provide AI-based surgical insights for laparoscopic surgical robots and other robot-assisted surgeries.

On July 15, Medtronic's Digital Surgery division announced on LinkedIn that the new live streaming feature has been commercially launched in the United States and other regions.

This live streaming feature update creates an immersive learning environment with the advantage of actual presence.

The company's goal is to enable surgeons to acquire professional skills, targeting surgeons, interns, and operating room managers.Can initiate or participate in live broadcasts to gain access to high-quality frontline surgical education resources.

According to Medtronic, the live streaming feature coversAbdomenLaparoscopic cholecystectomy, laparoscopic sleeve gastrectomy, and robot-assisted hysterectomy, among other procedures.

Touch Surgery also provides AI-driven solutions for hospitalsSurgical Video Management Platform and Digital Solutions, this is the world's first AI-driven surgical video storage and analysis platform.

Upload surgical videos within minutes, and Touch Surgery will anonymize them to ensure privacy.
Subsequently, its developed AutoPhase™ platform will complete the process within 72 hours.Automatically Return Surgical Process Analysis Results, capable of performing phase-time analysis on specific surgical procedures selected by the user.
Users can add content annotations to surgical videos and access them on their phones.

Touch Surgery Is the first artificial intelligence-driven surgical video and analytics platform, representing a significant leap forward in the field of digital surgery.

# About Medtronic

Medtronic is a global leading medical technology company, founded in 1949, with its headquarters located in Minnesota, USA. The main product lines of Medtronic areCardiovascular, surgery and critical care, neuroscience, and diabetes—the four major businesses cover products and service systems in the treatment areas of arrhythmia, heart failure, cardiac intervention, heart valve replacement, diabetes, gastrointestinal diseases, urinary system diseases, spinal diseases, nervous system diseases, and ENT.

As a technology company, Medtronic is also committed to researching and developing new medical technologies to improve patients' quality of life. The company has numerous research and development centers and production bases worldwide, with a total workforce of over 90,000 employees. Medtronic's business spans more than 150 countries and regions globally.

On May 23, 2024, Medtronic released its latest financial report.Total revenue in 2023 was $31.227 billion (approximately 224.8 billion RMB), with a net profit margin of 12%, ranking second in sales volume in the global medical device market.

Well-known Surgical Robotics Companies in China:

Minimally Invasive Robot | Rosenthal | Aibohc

MetaNova Intelligence | Born Medical | Medtronic | Xin Jun Te

Sizherui Intelligent Medical | Toda Medical | Changmu Valley

Medtronic| True Health| Surui

Updates from Other Surgical Robotics Companies:

Progress of Chinese Surgical Robot Companies | Progress of Overseas Surgical Robotics Companies

Intelligent Surgery Innovation Enterprise:

Medtronic｜With Rui Innovation｜Good Doctor

2024 Surgical Robotics Industry Awards:

33 Companies Win 2024 Global Surgical Robotics Industry Awards!